Plakortinic acids A and B: cytotoxic cycloperoxides with a unique bicyclo[4.2.0]octene unit from sponges of the genera <i>Plakortis </i>and <i>Xestospongia</i>
11198678 · 2021-12-14
Assignee
Inventors
Cpc classification
International classification
Abstract
Plakortinic acids A (2) and B (3), two polyketide endoperoxides having an unprecedented bicyclo[4.2.0]octene unit, were isolated as minor constituents from the sponge-sponge symbiotic association Plakortis halichondrioides-Xestospongia deweerdtae from Puerto Rico, along with the known epiplakinic acid F (1). The molecular structures of 2 and 3 were determined mainly on the basis of NMR spectroscopy. Due to the structural similarities, 2 and 3 are thought to be biosynthetically related to 1. Biological screening for cytotoxic activity against two human tumor cell lines revealed that these novel metabolites are very active at low to sub-micro molar concentration.
Claims
1. An isolated compound consisting of: ##STR00001## wherein R═ CH.sub.3.
Description
BRIEF DESCRIPTION OF THE DRAWINGS
(1) Further features and advantages of the invention will become apparent from the following detailed description taken in conjunction with the accompanying figures showing illustrative embodiments of the invention, in which:
(2)
(3)
(4)
(5)
(6)
(7)
(8)
(9)
(10)
(11)
(12)
(13)
(14)
(15)
(16)
(17)
(18)
(19)
(20)
(21)
(22)
(23)
(24)
(25)
(26) Throughout the figures, the same reference numbers and characters, unless otherwise stated, are used to denote like elements, components, portions or features of the illustrated embodiments. The subject invention will be described in detail in conjunction with the accompanying figures, in view of the illustrative embodiments.
DETAILED DESCRIPTION OF THE INVENTION
(27) In general terms, the compounds were obtained by cutting the sponge specimens into small blocks and blending with MeOH—CHCl.sub.3. After filtration, the extract was concentrated to yield a gum that was suspended in H.sub.2O and extracted with n-hexane. After concentration, a portion of the oil obtained was chromatographed with n-hexane-acetone. Fractionation and purification of active components guided by our cytotoxicity assay resulted in the isolation of two novel, highly cytotoxic polyketide derived metabolites, plakortinic acid A (2, 8.0 mg, 0.01% yield), and its counterpart plakortinic acid B (3), along with known epiplakinic acid F (1, 170 mg, 0.21% yield), which had been isolated before from this sponge genus. Treatment of an aliquot of 3 with CH.sub.2N.sub.2 followed by successive CC and RP-HPLC yielded the methyl ester of plakortinic acid B (4, 12.0 mg, 0.02% yield), which was suitable for structure elucidation work.
Experimental Section
General Experimental Procedures
(28) Optical rotations were obtained with an Autopol IV automatic polarimeter. Infrared spectra were obtained with a Nicolet Magna FT-IR 750 spectrometer. 1D- and 2D-NMR spectra were recorded with a Bruker DRX-500 FTNMR spectrometer. Mass spectrometric data were generated at the Mass Spectrometry Laboratory of the University of Illinois at Urbana-Champaign. Column chromatography (CC) was performed using silica gel (35-75 mesh). TLC analysis was carried out using glass pre-coated silica gel plates, and the spots were visualized by exposure to I.sub.2 vapor. All solvents used were either spectral grade or distilled from glass prior to use. Commercially available Diazald® and dimolybdenum tetraacetate were purchased from Sigma Aldrich Co.
(29) Animal Material
(30) All individuals, found along the ceiling of cave overhangs with a drop shape, were massively encrusting with irregular conulose surface. Most specimens collected measured up to 20 cm long and 5 cm thick. All Plakortis halichondrioides colonies were overgrown with the thinly-encrusting sponge Xestospongia deweerdtae, which provides a lavender pink crust over the olive green color of P. halichondrioides. However, specimens turned to a brownish color, producing a dark exudate when brought to the surface. Individuals were easily broken, with firm consistency. Noticeable oscules along the surface were circular and measured 2.0-10.0 mm in diameter. The choanosome was compact with many cavities. Both choanosome and ectosome formed by high abundance of diods that were arranged homogenously and densely over the sponge body. Diods were curved with sharp edges. Straight triods with sharp edges were highly abundant. Nonetheless, many triods had rounded edges with a thick center. Triods and diods were variable in size. Minimum diod length varied from 110 to 160 μm, and the maximum actine length of triod length varied between 20 and 60 μm. The ectosome measured between 450 and 650 μm thick. A high density of unusual cavities formed a mesh that ran perpendicular to the surface of the ectosome. An underwater photograph of one of the sponge specimens is shown in
(31) Collection, Extraction, and Isolation
(32) Fresh specimens of the sponge Plakortis halichondrioides (phylum Porifera; class Demospongiae; subclass Homoscleromorpha; order Homosclerophorida; family Plakinidae) were collected by hand using scuba at depths of 90-100 ft off Mona Island, Puerto Rico. A voucher specimen (No. IM06-09) is stored at the Chemistry Department of the University of Puerto Rico, Río Piedras Campus. The organism was frozen and lyophilized prior to extraction. The dry specimens (395 g) were cut into small pieces and blended in a mixture of CHCl.sub.3-MeOH (1:1) (11×1 L). After filtration, the crude extract was concentrated and stored under vacuum to yield a dark gum (100 g), which was suspended in H.sub.2O (2 L) and extracted with n-hexane (3×2 L), CHCl.sub.3 (3×2 L), and EtOAc (3×2 L). Concentration under reduced pressure yielded 16.4 g of the n-hexane extract as a dark brown oil, a portion of which (3.7 g) was chromatographed over silica gel (130 g) using mixtures of n-hexane-acetone of increasing polarity (0-100%). A total of 11 fractions (I-XI) were generated on the basis of TLC and .sup.1H NMR analysis. Further purification of fraction II (1.3 g) by silica gel (20.0 g) column chromatography in 2% acetone-n-hexane afforded eight sub-fractions, denoted as A-H. Purification of fraction B (659.1 mg) by silica gel (13.0 g) CC using CHCl.sub.3 100% as eluent afforded a mixture enriched with plakortinic acid B (3) (22 mg, 0.04% yield). The more polar fraction H (215 mg) was subjected to CC using reverse-phased silica gel (5 g) and eluted with a MeOH—H.sub.2O gradient (6:4; 7:3; 8:2; 9:1; 1:0) to yield 7 sub-fractions denoted as H1-H7. Subfraction H4 (30 mg) was purified through a short plug of silica gel (0.8 g) with a CHCl.sub.3-MeOH gradient (10:0; 9.5:0.5; 9:1) to afford plakortinic acid A (2) (8.0 mg, 0.01% yield). Purification of subfraction II (H) (659.1 mg) by silica gel (13.0 g) CC using CHCl.sub.3 as eluent afforded the known epiplakinic acid F (1) (170 mg, 0.21% yield).
(33) Methylation of Plakortinic Acid B (3)
(34) To a solution of impure compound 3 (22 mg, 0.052 mmol) in CHCl.sub.3 (8 mL) was added a solution of diazomethane in ether (10 mL), and the resulting mixture was stirred at 25° C. for 2 h. The oily residue obtained after concentration was chromatographed using a short plug of silica gel (1.0 g) and a mixture of n-hexane-acetone (95:5) to yield three fractions (I-III). Fraction II (15 mg) was submitted to reversed-phased HPLC chromatography (column: RP Analytical Hypersil 5μ C.sub.18 250×4.6 mm) using isocratic elution with MeCN—H.sub.2O (85:15, flow rate: 0.80 mL/min). After HPLC purification, four sub-fractions were obtained (IIa-d). Subfraction IIc yielded compound 4 (12.0 mg, 53% yield) as an inseparable mixture in 3:1 ratio based on .sup.1H NMR integration.
(35) The present invention will be explained in conjunction with the NMR spectra shown in
(36) TABLE-US-00001 TABLE 1 NMR Spectroscopic Data for 2 in CDCl.sub.3 position δ.sub.C.sup.a δ.sub.H.sup.b (J in Hz) HMBC (H.fwdarw.C#) 1 174.5, C 2a 43.9, CH.sub.2 2.76, d (14.8) 1, 3, 4, 22 2b 2.72, d (14.8) 1, 3, 4, 22 3 83.9, C 4a 55.7.sup.c, CH.sub.2 2.25, d (12.5).sup.c 2, 3, 5, 6, 7, 22, 23 4b 2.44, d (12.5).sup.c 2, 3, 5, 6, 22, 23 5 86.6.sup.c, C 6ab 39.5, CH.sub.2 1.70, m; 1.53, m 7 7ab 24.3.sup.c, CH.sub.2 1.38, m; 1.30, m 8 29.8c, CH.sub.2 1.30, m 9 29.7, CH.sub.2 1.30, m 10ab 28.2.sup.c, CH.sub.2 1.39, m; 1.28, m 11ab 30.7, CH.sub.2 1.58, m; 1.38, m 9, 12 12 39.8, CH 2.03, m 20 13 35.6.sup.c, CH 2.41, q (8.9 Hz) 12, 14, 18, 19 14 68.9.sup.c, CH 3.93, dd (9.7, 12, 13 3.3) 15 67.8, CH 4.11, dd (5.8, 13, 14, 16, 17 3.3) 16 121.3, CH 5.56, d (5.8) 14, 15, 18, 24 17 143.1, C 18 42.1, CH 2.34, t (8.4) 13, 14, 16, 17, 19, 20, 24 19 49.2, CH 1.66, m 12, 18, 21 20ab 28.8, CH.sub.2 1.58, m; 1.49, m 12, 18, 19, 21 21 11.9, CH.sub.3 0.91, t (7.5) 19, 20 22 23.8, CH.sub.3 1.46, s 2, 3, 4 23 23.2.sup.c, CH.sub.3 1.29, s 4, 5, 6, 7 24 21.3, CH.sub.3 1.65, s 16, 17, 18 .sup.aRecorded at 125 MHz. Multiplicities were obtained from a DEPT-135 experiment. .sup.bRecorded at 500 MHz. .sup.cTwo sets of signals with partial overlap)
(37) The relative configurations of the stereocenters of the strained ring systems in plakortinic acid A (2) were established on the basis of correlations in the NOESY NMVR spectrum as well as through interpretation of NMVR coupling constant data (Table 1). The H.sub.2-4 proton (δ.sub.H 2.44) that is cis to the acetic acid side chain appears downfield from the proton trans to the acetic acid. Thus, H-4b showed strong dipolar coupling to H.sub.3-23. H-4a (δ.sub.H 2.25) showed strong dipolar couplings to H.sub.3-22 and H.sub.2-6. All of these are consistent with a trans relative stereochemistry for the 1,2-dioxolane carboxylic acid moiety of 2. The assignments shown in 2 of C-3 and C-5 are not arbitrary. Rather, they are based on nearly identical NMR and [α].sub.D data plus the NOESY experiments which showed correlations identical to those reported for the co-isolated known compound 1. Cross-peaks of H-13 with H-12 and H-18, and of H-12 with H.sub.3-21 placed these protons on the same face of the bicyclo ring system. Due to the near coincidence in chemical shifts between H-13 and H-18 in CDCl.sub.3, no consideration about their relative orientation could be established on the basis of NOESY experiments. However, in Bz-d.sub.6 greater dispersion in the chemical shifts made it possible to detect an NOE cross-peak between these nuclei. While those of H-14 with H.sub.2-11, H-15, and H-19 were used to place them on the opposite face. The conspicuous absence of NOE's between H-19, H-12, and H-18 confirmed their trans quasi-diaxial relationship. The coupling constant for H-13 and H-14 (J=9.7 Hz) is in full agreement with their trans-diaxial orientation, whereas the small coupling constant between H-14 and H-15 (J=3.3 Hz) supports the cis geometry for the 1,2-diol array in 2. Therefore, the relative configuration of plakortinic acid A (2) was determined to be 3S*, 5R*, 12S*, 13S*, 14R′, 15S*, 18R′, 19S*. An attempt to assign the absolute configuration of the 14,15-diol moiety in 2 using the dimolybdenum CD method was unsuccessful as the CD spectrum did not display a measurable Cotton effect.
(38) Plakortinic acid B methyl ester (4) was obtained also as an optically active substance. Plakortinic acid B methyl ester (4): colorless oil; [α].sub.D.sup.20=+12.6° (c 0.54, CHCl.sub.3); IR (film) u.sub.max 2932, 2854, 1738, 1456, 1376, 1210, 1088, 1012, 715 cm.sup.−1; HRESIMS m/z [M+H]+437.2910 (calcd for C.sub.25H.sub.40O.sub.6, 437.2903). Its HRESIMS indicated a [M+H].sup.+ ion peak at m/z 437.2910, suggesting a molecular formula of C.sub.25H.sub.40O.sub.6, from which 6 degrees of unsaturation could be deduced. The .sup.13C NMR and DEPT-135 NMR spectra (Table 2) exhibited 25 signals for 5 methyl, 9 methylene, 7 methine, and 4 quaternary carbons. The 1D and 2D NMR spectra of 4 revealed strong structural analogies with compound 2, suggesting the presence of the same carbon skeleton. However, in place of a cyclohex-3-ene-1,2-diol system, compound 4 was characterized by a methine linked to an oxygen atom (δ.sub.H 4.63, H-14; δ.sub.c 72.5, C-14), an oxygenated tertiary sp.sup.3 carbon at δ.sub.c 77.3 (C-17), and a 1,2-disubstituted double bond [δ.sub.H 6.76 (H-15), 6.34 (H-16); δ.sub.c 132.6 (C-15), 135.8 (C-16)]. According to these data, a peroxide bridge across C-14/C-17 was suggested for compound 4. Conceivably, compound 3 could be an artifact formed during work-up via 1,4-addition of O.sub.2 to a bicyclo[4.2.0]octadiene precursor. The remaining part of the molecule was the same as 2. All proton and carbon resonances were attributed as reported in Table 2 by detailed NMR analysis (.sup.1H-.sup.1H COSY, HSQC, and HMBC).
(39) In spite of their structural dissimilarities, epiplakinic acid F (1) and plakortinic acid A (2) have [α].sub.D values of the same positive sign and similar magnitudes. Although this could be dismissed as a coincidence, it might also imply that plakortinic acid A actually consists of an inseparable mixture of two diastereomers, namely, 2 (3S*, 5R*, 12S*, 13S*, 14R*, 15S*, 18R*, 19S*) and 2′ (3S*, 5R*, 12R*, 13R*, 14S*, 15R*, 18S*, 19R*). In order to account for this interpretation, as shown in
(40) As a second rationale, as mentioned earlier, in the case of plakortinic acid A, the initial characterization by .sup.1H and .sup.13C NMR was complicated because of the duplication of some of the proton and carbon signals. Conceivably, rotation around the straight alkyl chain gives rise to (at least) two quickly interchanging rotational isomers with subtle different chemical shift values in a ratio of approximately 1:1. Unfortunately, we did not try to confirm this phenomenon by running the experiments in DMSO-d.sub.6 (with the hope of observing the coalescence of the duplicating peaks). Rotational isomerization is a reasonable rationale given the inherent conformational flexibility introduced by the —(CH.sub.2).sub.6— bridge of 2 and 3.
(41) TABLE-US-00002 TABLE 2 NMR Spectroscopic Data for 4 in CDCl.sub.3 position δ.sub.c.sup.a δ.sub.H.sup.b (J in Hz) HMBC (H.fwdarw.C#) 1 171.1 C 2a 44.0, CH.sub.2 2.76, d (14.5) 1, 3, 4, 22 2b 2.65, d (14.5) 1, 3, 4, 22 3 83.9, C 4a 55.4, CH.sub.2 2.22, d (12.6) 2, 3, 5, 6, 22 4b 2.47, d (12.6) 2, 3, 5, 6, 23 5 86.4, C 6ab 39.6, CH.sub.2 1.69 m; 1.52, m 7 24.4, CH.sub.2 1.32, m 8 29.6, CH.sub.2 1.25, m 9 29.6, CH.sub.2 1.25, m 10 28.3, CH.sub.2 1.13, m 11 30.7, CH.sub.2 1.35, m 12 31.3, CH 2.04, m 11, 13, 14 13 35.2, CH 3.04, ddd (9.2, 14, 18 9.0, 4.8) 14 72.5, CH 4.63, t (5.3) 13, 15, 16, 18 15 132.6, CH 6.76, dd (8.1, 13, 14, 17 6.2) 16 135.8, CH 6.34, d (8.1) 14, 17, 18, 24 17 77.3, C 18 42.5, CH 2.30, dd (8.3, 13, 16, 17, 20, 24 5.8) 19 44.8, CH 1.52, m 12, 17, 20 20ab 29.9, CH.sub.2 1.38, m; 1.28, m 21 21 11.9, CH.sub.3 0.81, t (7.3) 19, 20 22 24.1, CH.sub.3 1.43, s 2, 3, 4 23 23.2, CH.sub.3 1.28, s 4, 5, 6 24 20.5, CH.sub.3 1.32, s 16, 17, 18 —OCH.sub.3 51.7, CH.sub.3 3.69, s 1 .sup.aRecorded at 125 MHz. Multiplicities were obtained from a DEPT-135 experiment. .sup.bRecorded at 500 MHz
(42) The relative stereochemistry of compound 4, suggested by comparison of their proton and carbon chemical shifts, was based mainly on NOESY experiments. The expected cis geometry of the 13,18 junction was suggested by a diagnostic NOE effect between the angular methines at those sites. The peroxide bridge was α-oriented with respect to the plane of the bicyclo[4.2.0]octene by the downfield shift of H-13, which in compound 4 resonated at δ 3.04 vs δ 2.41 of 2, suggesting that both the peroxide unit and the angular methine at C-13 were on the same side of the molecule. Additional NOE's, particularly H-16/H-19, H.sub.2-11/H-15, H-12/H-13 and H-18/H.sub.3-21 fixed the relative stereochemistry shown in 4.
(43) Compounds 1 and 2 have common structural features, including almost coincidental molecular formula and specific rotation. Except for a branching methyl group, both have identical 1,2-dioxolane rings and same-length side chains. Considering these structural features, 1 is likely a putative biogenetic precursor of 2 and 3 as shown in
(44) Compounds 2 and 4 were found to be primarily responsible for the cytotoxicity of the crude extract of the sponge.
(45) Cytotoxicity Assays
(46) DU-145 human prostate cancer and A2058 melanoma cell lines were obtained from ATCC. These cells were cultured in RPMI-1640 or DMEM medium containing 10% fetal bovine serum (FBS), 100 units/mL penicillin, and 100 μg/mL streptomycin. All cells were maintained in a 5% CO.sub.2 atmosphere at 37° C. To determine the viability of the cells, Promega CellTiter 96 aqueous nonradioactive cell proliferation assays (MTS) were performed as described by the supplier (Promega; Madison, Wis.). Briefly, cells (5000/well) were seeded in 96-well plates and incubated overnight at 37° C. in 5% CO.sub.2. Cells were treated for 48 h with each compound. The concentration used was 10 μM. Dimethyl sulfoxide (DMSO) was used as the vehicle control. IC.sub.50 values of compounds were determined in a dose-dependent manner (0.1, 0.5, 1, 5, 10, 20, and 50 μM). Cell viability was determined by tetrazolium conversion to its formazan dye, and absorbance of formazan was measured at 490 nm using an automated ELISA plate reader. The production of formazan dye was directly proportional to the number of living cells. Each experiment was done in quadruplicate in the absence of a positive control.
(47) Although the present invention has been described herein with reference to the foregoing exemplary embodiment, this embodiment does not serve to limit the scope of the present invention. Accordingly, those skilled in the art to which the present invention pertains will appreciate that various modifications are possible, without departing from the technical spirit of the present invention.